Regulation of Death and Growth Signals at the Plasma Membrane by Sphingomyelin Synthesis: Implications for Hematological Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 2212-3970|6|3|324-333

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.6, Iss.3, 2011-09, pp. : 324-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulation of Sphingosine Kinase in Hematological Malignancies and Other Cancers

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 9, 2011-11 ,pp. : 799-809

Bentham Science Publishers

Access to resources Recommend Favorite

Coagulation in Hematological Malignancies

By Falanga Anna   Vignoli Alfonso   Marchetti Marina  

Cancer Investigation, Vol. 27, Iss. 1, 2009-01 ,pp. : 7-16

Informa Healthcare

Access to resources Recommend Favorite

High plasma levels of oxidatively modified low-density lipoproteins are associated with the suppressed expression of immunomodulatory molecules in patients with hematological malignancies

By          

Experimental and Therapeutic Medicine, Vol. 9, Iss. 6, 2015-01 ,pp. : 2394-2400

Spandidos Publications

Access to resources Recommend Favorite

Nanotechnology applications in hematological malignancies (Review)

By        

Oncology Reports, Vol. 34, Iss. 3, 2015-01 ,pp. : 1097-1105

Spandidos Publications

Access to resources Recommend Favorite

Role of mTOR in Hematological Malignancies

By  

Current Cancer Therapy Reviews, Vol. 4, Iss. 3, 2008-08 ,pp. : 211-218

Bentham Science Publishers

Access to resources Recommend Favorite